Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | PEPD | P12955 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | IKBKB | O14920 | 1/20 | 0.47 |
| ▸ | TOP1 | P11387 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29840068 | 1.00 | GAA (0.67) | GAAKDM4EALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL15259585 | 0.89 | KDM4E (0.57) | GAAKDM4EALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL7417077 | 0.89 | GAA (0.57) | GAAKDM4EALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL30275531 | 0.87 | ALDH1A1 (0.58) | GAAKDM4EALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL250263 | 0.87 | HDAC3 (0.64) | GAAKDM4EMAPK1NPC1RAB9A | |
| SCHEMBL29807803 | 0.87 | GAA (0.61) | GAAKDM4EALDH1A1MAPTLMNA | |
| SCHEMBL11649214 | 0.87 | GAA (0.61) | GAAKDM4EALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL11760578 | 0.87 | GAA (0.61) | GAAKDM4EALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL5545365 | 0.87 | GAA (0.55) | GAAKDM4EALDH1A1SMN1; SMN2RECQL | |
| SCHEMBL3859948 | 0.87 | GAA (0.61) | GAAKDM4EALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7459014-B2 | Radiation curable inks containing curable gelator additives | XEROX CORPORATION (US) | 2008-12-02 | — | — | US | claimed |
| EP-1681323-B1 | Radiation curable inks | XEROX CORP (US) | 2007-10-31 | — | — | EP | claimed |
| US-20060159850-A1 | Radiation curable inks containing curable gelator additives | XEROX CORPORATION (US) | 2006-07-20 | — | — | US | claimed |
| EP-1681323-A1 | Radiation curable inks | Xerox Corporation (US) | 2006-07-19 | — | — | EP | claimed |
| US-11046645-B2 | Isothiocyanate production method, composition for transporting and storing N-substituted O-substituted thiocarbamate, and isothiocyanate composition | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2021-06-29 | — | — | US | disclosed |
| EP-2641896-B1 | SEPARATION METHOD | ASAHI CHEMICAL IND (JP) | 2020-10-14 | — | — | EP | disclosed |
| EP-3363785-B1 | ISOTHIOCYANATE PRODUCTION METHODS | ASAHI CHEMICAL IND (JP) | 2020-09-16 | — | — | EP | disclosed |
| US-20190233371-A1 | Isothiocyanate Production Method, Composition for Transporting and Storing N-Substituted O-Substituted Thiocarbamate, and Isothiocyanate Composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-08-01 | — | — | US | disclosed |
| EP-3214071-B1 | ISOTHIOCYANATE COMPOSITION | ASAHI CHEMICAL IND (JP) | 2019-07-03 | — | — | EP | disclosed |
| US-10308601-B2 | Isothiocyanate production method, composition for transporting and storing N-substituted O-substituted thiocarbamate, and isothiocyanate composition | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2019-06-04 | — | — | US | disclosed |
| EP-3363785-A1 | ISOTHIOCYANATE PRODUCTION METHODS | Asahi Kasei Chemicals Corporation (JP) | 2018-08-22 | — | — | EP | disclosed |
| US-9950273-B2 | Method of separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-04-24 | — | — | US | disclosed |
| EP-1631261-A2 | PRODUCTION OF SMALL PARTICLES | Applied NanoSystems B.V. (NL) | 2006-03-08 | — | — | EP | disclosed |
| WO-2004103347-A2 | PRODUCTION OF SMALL PARTICLES | APPLIED NANOSYSTEMS B.V. (NL) | 2004-12-02 | — | — | WO | disclosed |
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | L'OREAL (FR) | 2003-05-15 | — | — | US | disclosed |
| EP-1264589-A1 | Use of a polar additive in a cosmetic composition containing a structured liquid oil phase by at least one organogelator to give a thixotropic character | L'OREAL (FR) | 2002-12-11 | — | — | EP | disclosed |
| EP-0024526-B1 | EPOXY BASED SYNTHETIC SOLDER | AMERICAN CYANAMID COMPANY (US) | 1984-06-13 | — | — | EP | disclosed |
| US-4273686-A | 1,1'-O-PHENYLENEBIS(3,3-DIMETHYLUREA), DICYANDIAMIDE, FILLER, QUICK-SETTING | AMERICAN CYANAMID COMPANY (US) | 1981-06-16 | — | — | US | disclosed |
| EP-0024526-A2 | Epoxy based synthetic solder | AMERICAN CYANAMID COMPANY (US) | 1981-03-11 | — | — | EP | disclosed |
| US-3940365-A | PHENOLIC ANTIOXIDANT AND AN UREA OR AN OXALIC ACID DIAMIDE OR AN AZODICARBOXYLIC AMIDE | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11046645-B2 | Isothiocyanate production method, composition for transporting and storing N-substituted O-substituted thiocarbamate, and isothiocyanate composition | TST, SLCO4C1, SLCO2B1 | GAA 2074/4885KDM4E 4047/4885ALDH1A1 723/4885 |
| US-20190233371-A1 | Isothiocyanate Production Method, Composition for Transporting and Storing N-Substituted O-Substituted Thiocarbamate, and Isothiocyanate Composition | TST, SLCO4C1, SLCO2B1 | GAA 2074/4885KDM4E 4047/4885ALDH1A1 723/4885 |
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | PLIN3, CUTA, FABP4 | GAA 4196/4885KDM4E 3681/4885ALDH1A1 2187/4885 |
| US-10308601-B2 | Isothiocyanate production method, composition for transporting and storing N-substituted O-substituted thiocarbamate, and isothiocyanate composition | TST, SLCO4C1, SLCO2B1 | GAA 2074/4885KDM4E 4047/4885ALDH1A1 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.